We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Paychex
PAYX
$42.7B
| $330K | ﹤0.01% |
+5,366
| New | +$355K |
|
552
Best Buy
BBY
$17.3B
| $329K | ﹤0.01% |
4,705
-954
| -17% | -$68.6K |
|
553
National Fuel Gas
NFG
$7.65B
| $313K | ﹤0.01% |
+6,081
| New | +$318K |
|
554
Cencora
COR
$61.2B
| $312K | ﹤0.01% |
3,621
+462
| +15% | +$44.4K |
|
555
General Mills
GIS
$19.7B
| $312K | ﹤0.01% |
+6,927
| New | +$376K |
|
556
AES
AES
$10.5B
| $306K | ﹤0.01% |
26,901
-3,321
| -11% | -$36.1K |
|
557
H&R Block
HRB
$5.86B
| $297K | ﹤0.01% |
11,702
-698
| -6% | -$18.4K |
|
558
CenterPoint Energy
CNP
$26.8B
| $295K | ﹤0.01% |
10,762
+464
| +5% | +$12.6K |
|
|
ETP
559
DELISTED
Energy Transfer Partners, L.P.
ETP
| $294K | ﹤0.01% |
18,105
-385
| -2% | -$7.15K |
|
560
Trane Technologies
TT
$106B
| $293K | ﹤0.01% |
3,423
-830
| -20% | -$74.5K |
|
561
FirstEnergy
FE
$27.5B
| $267K | ﹤0.01% |
7,863
-1,688
| -18% | -$54.2K |
|
562
Motorola Solutions
MSI
$77.4B
| $247K | ﹤0.01% |
+2,342
| New | +$239K |
|
563
Kohl's
KSS
$2.19B
| $182K | ﹤0.01% |
+2,782
| New | +$177K |
|
|
UN
564
DELISTED
Unilever NV New York Registry Shares
UN
| $180K | ﹤0.01% |
3,191
+2,275
| +248% | +$125K |
|
|
SHPG
565
DELISTED
Shire pic
SHPG
| $180K | ﹤0.01% |
1,208
+862
| +249% | +$119K |
|
566
Diageo
DEO
$53.6B
| $165K | ﹤0.01% |
1,221
+872
| +250% | +$121K |
|
567
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.5B
| $159K | ﹤0.01% |
+660
| New | +$166K |
|
568
BGC Group
BGC
$4.89B
| $150K | ﹤0.01% |
17,344
-14,908
| -46% | -$134K |
|
569
Target
TGT
$68B
| $142K | ﹤0.01% |
+2,047
| New | +$149K |
|
570
Vanguard Morningstar Growth ETF
VUG
$230B
| $99K | ﹤0.01% |
4,188
-230,478
| -98% | -$5.62M |
|
571
Mastercard
MA
$493B
| $93K | ﹤0.01% |
530
-1,220
| -70% | -$209K |
|
|
GM.WS.B
572
DELISTED
General Motors Company
GM.WS.B
| $91K | ﹤0.01% |
4,859
| – | – |
|
573
Western Digital
WDC
$150B
| $82K | ﹤0.01% |
1,175
-63
| -5% | -$4.24K |
|
|
AET
574
DELISTED
Aetna Inc
AET
| $58K | ﹤0.01% |
341
-1,599
| -82% | -$287K |
|
575
Macy's
M
$6.68B
| $55K | ﹤0.01% |
+1,857
| New | +$50.2K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.